KTPPF yields 400000.00% · JNJ yields 2.14%● Live data
📍 KTPPF pulled ahead of the other in Year 1
Combined, KTPPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KTPPF + JNJ for your $10,000?
Katipult Technology Corp. operates as a financial technology company. The company offers a cloud-based software infrastructure that allows firms to design, set up, and operate an investment platform, which enables firms to offer debt and real-estate financing; and securities on a prospectus-exempt basis to various types of investors. Its platform automates various components of investor and investment management, including components of financial transactions, investment marketing, and dividend payouts, as well as manages regulatory requirements in various geographic jurisdictions. The company's platform includes modules for various user types, including investors, issuers, administrators, and auditors. It serves customers worldwide. The company was formerly known as Deha Capital Corp. and changed its name to Katipult Technology Corp. in August 2017. Katipult Technology Corp. was founded in 2008 and is headquartered in Calgary, Canada.
Full KTPPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.